Steven Yatomi Clarke – CEO and Managing Director – Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies.
Copyright 2023 – Finance News Network
Source: Finance News Network
22 May 2023 - Kalamazoo Resources Limited (ASX:KZR) CEO and Chairman Luke Reinehr discusses plans to spin out the company's lithium projects into a new ASX-listed exploration company in an agreement with TSX-listed Canadian gold miner Karora Resources.
Read More21 Sep 2023 - Phil McNamara - Director - Emperor Energy (ASX:EMP) is a diversified energy company with upstream and downstream assets in Australia. The company’s strategic asset Vic/P47 in the Gippsland Basin next to the BHP/ExxonMobil Kipper field.
Read More20 May 2021 - Complii FinTech Solutions Limited (ASX:CF1) Executive Chairman Craig Mason talks about how the company's digital platform provides an electronic centralised framework to manage AFSL-centric (Stockbroker/Financial Planner/Adviser) workflows for compliance, capital raising and operational efficiencies.
Read More02 Sep 2019 - Lithium Consolidated Limited (ASX:LI3) CEO, Shanthar Pathmanathan talks about the company's capital raising and focus on hard rock lithium and sale of its US lithium brine asset to Argosy Minerals.
Read More28 Aug 2024 - Focused on supplying high-purity manganese for electric vehicles, Euro Manganese Limited (ASX:EMN) is advancing a project in the Czech Republic that repurposes historical mine tailings. The company's recent offtake agreement with Wildcat Discovery Technologies is a significant milestone, with more agreements and funding efforts planned for the near future.
Read More06 Sep 2021 - Paragon Care Limited (ASX:PGC) CEO Phil Nicholl provides an update on FY21 results, which reported growth in all key financial metrics and the recommencement of dividends.
Read More15 Nov 2022 - OncoSil Medical Limited (ASX:OSL) Non-Executive Director Brian Leedman discusses joining the board of OncoSil and receiving CE mark approval for the company's therapy.
Read More15 Jan 2021 - Famed investor, author and market analyst Jim Rogers discusses the impact of the COVID-19 vaccine rollout, Chinese wine stocks, the bond bubble, why he is bullish on commodities, allegations of currency manipulation and how Aussie investors can get ahead.
Read More19 Aug 2022 - Sequoia Financial Group Limited (ASX:SEQ) Managing Director Garry Crole discusses FY22 financial highlights, future margin growth, acquisition strategy and dividend policy.
Read More20 Aug 2025 - Sovereign Advisors Principal Advisor Zaheer Lalani and Investment Manager Max Riaz provide a quarterly update on the markets.
Read More
